Compare NGNE & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NGNE | PINE |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.8M | 277.5M |
| IPO Year | 2014 | 2019 |
| Metric | NGNE | PINE |
|---|---|---|
| Price | $27.00 | $19.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $63.57 | $20.10 |
| AVG Volume (30 Days) | ★ 138.7K | 108.0K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 6.10% |
| EPS Growth | ★ 0.93 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $60,532,000.00 |
| Revenue This Year | N/A | $18.63 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.90 |
| 52 Week Low | $11.78 | $13.10 |
| 52 Week High | $37.27 | $20.80 |
| Indicator | NGNE | PINE |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 61.26 |
| Support Level | $19.40 | $13.88 |
| Resistance Level | $29.05 | $20.80 |
| Average True Range (ATR) | 1.86 | 0.40 |
| MACD | 0.53 | 0.08 |
| Stochastic Oscillator | 78.73 | 85.80 |
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.